Medipharm Labs Corp MEDIF

Primary Symbol: T.LABS

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Apr 20, 2024 11:49am

110 Views

Post# 35999522

Yet to be made public: 4 new drug approvals for LABS....

2 in Brazil and 2 in the U.S.

CEO said they have 1 approved in Brazil and will make the press release when the 2nd is approved.

Again....JAZZ paid 7.2 billion for a one pony show with GW Pharma and Epidiolex.

4 new drug approvals....has to be worth at least that much or $17.82 per share for LABS, not adusted for inflation either.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects